Immunoscore® for Clinical Research The next generation immunoscore® featured by spatially resolved phenotypic imaging data to mine the immune contexture

IMMUNOSCORE® for Clinical Research (CR)

Leverage HalioDx know how acquired with Immunoscore®, to propose an enhanced next generation Immunoscore® with multiplex and spatially resolved capabilities for clinical investigations.

  • Robust immunohistochemistry assays using standardized reagents
  • Classify tumors in hot/cold, exhausted/not exhausted and immunosuppressed/not immunosuppressed
  • Flexible multiplexing capabilities
  • Deliver spatially resolved phenotypic imaging data
  • Validated in several cancer types

    
A growing range of immune phenotypes are available:

  • T cells
  • T cells exhaustion
  • Suppressor cells (MDSC’s, T Reg, …)

Easy customization to include your biomarker of interest.

All assays are amenable to clinical trial assays and companion diagnostics.

More on our Assay Development capabilities Discover
See publications and posters on Immunoscore® CR Ressources
Want to learn more on Immunoscore® CR ? Contact us

HalioDx newsletter subscription


Join our newsletter and be the first to get notified on new updates.


× Hide this popup.